CM369

· Beijing InnoCare Pharma Tech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CM369, covering 2024-12-27 to 2024-12-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetic Characteristics, and Efficacy of CM369 in Advanced Solid Tumors & Hematologic Malignancies [Phase 1]

See pricing